AnaptysBio, Inc. (ANAB) Earnings
|
Expand Research on ANAB
| Next EPS Date | 11/4/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1,008.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/26  |
Q326 | N/A | -$0.64 | N/A | N/A | $18.86M | N/A | N/A | N/A | ||
| 9/22/26 |
Q226 | $5.11 | -$0.13 | +$5.24 | $27.5M | $20.22M | N/A |  | | Details | |
| 8/31/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/28/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/26/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/25/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/24/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/21/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A |
